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The well-known large catabolic potential of rhodococci is greatly facilitated by an impressive gene multi-
plicity. This study reports on the multiplicity of kshA, encoding the oxygenase component of 3-ketosteroid
9a-hydroxylase, a key enzyme in steroid catabolism. Five kshA homologues (kshA1 to kshA5) were previously
identiﬁed in Rhodococcus rhodochrous DSM43269. These KshADSM43269 homologues are distributed over sev-
eral phylogenetic groups. The involvement of these KshA homologues in the catabolism of different classes of
steroids, i.e., sterols, pregnanes, androstenes, and bile acids, was investigated. Enzyme activity assays showed
that all KSH enzymes with KshADSM43269 homologues are C-9 a-hydroxylases acting on a wide range of
3-ketosteroids, but not on 3-hydroxysteroids. KshA5 appeared to be the most versatile enzyme, with the
broadest substrate range but without a clear substrate preference. In contrast, KshA1 was found to be
dedicated to cholic acid catabolism. Transcriptional analysis and functional complementation studies revealed
that kshA5 supported growth on any of the different classes of steroids tested, consistent with its broad
expression induction pattern. The presence of multiple kshA genes in the R. rhodochrous DSM43269 genome,
each displaying unique steroid induction patterns and substrate ranges, appears to facilitate a dynamic and
ﬁne-tuned steroid catabolism, with C-9 a-hydroxylation occurring at different levels during microbial steroid
degradation.
Rhodoccoci are capable of degrading a wide range of or-
ganic compounds (15, 32). This strong catabolic potential is
encoded by an extremely large genome, of .9.7 Mb in the case
of Rhodococcus jostii RHA1, which also carries numerous gene
homologues for various enzyme classes (20). Multiple steroid
catabolic gene clusters, for example, have been identiﬁed in R.
jostii RHA1 (19, 20, 33). In particular, several homologous
genes encoding key enzymes involved in steroid ring opening
have been identiﬁed, i.e., 3-ketosteroid 9a-hydroxylase (KSH),
encoded by kshA and kshB, and 3-ketosteroid D1-dehydroge-
nase (KSTD), encoded by kstD (13, 33). Hydroxylation of ste-
roid substrates at the C-9 position, together with dehydroge-
nation of the A-ring performed by KSTD, leads to opening of
the steroid polycyclic ring structure and the formation of 3-hy-
droxy-9,10-secoandrost-1,3,5(10)-triene-9,17-dione (3-HSA)
(7, 31). Knowledge of steroid catabolic enzymes is limited,
despite the fact that sterol-degrading rhodococci and mycobac-
teria are of great industrial and pharmaceutical interest (6, 9,
12, 17, 25, 32). In recent years, interest in steroid catabolic
enzymes has gained momentum, following the discovery of
cholesterol catabolic gene clusters in R. jostii RHA1 and in the
human pathogen Mycobacterium tuberculosis H37Rv (33). In-
terestingly, kshA and kshB have been identiﬁed as essential
factors in the pathogenesis of M. tuberculosis H37Rv (10).
KSH is a two-component enzyme system, consisting of a
terminal oxygenase, KshA, and a ferredoxin reductase, KshB.
The kshA and kshB genes, encoding KshA and KshB, respec-
tively, were ﬁrst identiﬁed in Rhodococcus erythropolis SQ1, a
strain possessing at least 3 kshA homologues (31, 34). A crystal
structure of KshA of M. tuberculosis H37Rv was recently elu-
cidated and revealed that KshA of H37Rv likely functions as
a trimer (a3) (4). KshB from Rhodococcus rhodochrous
DSM43269 was shown to contain FAD as ﬂavin cofactor and a
plant-type Fe2S2 cluster (4, 24).
We previously reported the cloning, heterologous expres-
sion, and characterization of KshA and KshB from R. rhodo-
chrous DSM43269 (IFO3338) (1) and showed that this KSH
enzyme displayed activity toward a subtle range of saturated
and unsaturated 3-ketosteroid substrates (24). We have also
performed cloning of an additional four kshA homologous
genes from R. rhodochrous DSM43269 and the construction of
a 5-fold kshA null mutant strain, R. rhodochrous RG32,
blocked in steroid B-ring opening (35a). To investigate
whether each of these ﬁve homologous KshA proteins is ca-
pable of catalyzing steroid 9a-hydroxylation and to analyze
their physiological roles in steroid catabolism, we performed
functional complementation experiments with a kshA null mu-
tant strain, RG32 of R. rhodochrous DSM43269, which is
blocked in 4-androstene-3,17-dione (AD) degradation. More-
over, kshA transcriptional analyses of wild-type DSM43269
cells induced with a range of steroid substrates were per-
formed. Finally, a biochemical characterization of heterolo-
* Corresponding author. Mailing address: Department of Microbi-
ology, University of Groningen, Nijenborgh 7, 9747 AG Groningen,
Netherlands. Phone: 31 (50) 3632153. Fax: 31 (50) 3632154. E-mail:
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 gously expressed and puriﬁed KSH enzymes was undertaken to
determine the substrate range of the different KshA proteins
involved.
MATERIALS AND METHODS
Bacterial strains and growth conditions. Escherichia coli cloning strain DH5a
(Stratagene) and expression strains E. coli BL21(DE3) (Invitrogen) and E. coli
C41(DE3) (21) were grown in Luria-Bertani (LB) at 37°C, 200 rpm. Wild-type R.
rhodochrous DSM43269 was obtained from the DSMZ culture collection. The
construction of the 5-fold kshA mutant strain R. rhodochrous RG32 is described
elsewhere (35a). R. rhodochrous strains were grown in LB broth or mineral
medium at 30°C and 200 rpm. Mineral medium contained K2HPO4 (4.65 g
liter
21), NaH2PO4 z H2O (1.5 g liter
21), NH4Cl (3 g liter
21), MgSO4 z 7H2O (1
g liter
21), and Vishniac stock solution (1 ml liter
21). Vishniac stock solution was
prepared as follows (modiﬁed from the methods described in reference 35):
EDTA (10 g liter
21) and ZnSO4 z 7H2O (4.4 g liter
21) were dissolved in distilled
water (pH 8.0, adjusted by using 2 M KOH). Then, CaCl2 z 2H2O (1.47 g liter
21),
MnCl2 z 7H2O (1 g liter
21), FeSO z 7H2O (1 g liter
21), (NH4)6 Mo7O24 z 4H2O
(0.22 g liter
21), CuSO4 z 5H2O (0.315 g liter
21), and CoCl2 z 6H2O (0.32 g
liter
21) were added in that order at pH 6 and ﬁnally stored at pH 4.0. When
appropriate, ampicillin, apramycin, or kanamycin was added to a ﬁnal concen-
tration of 100, 50, or 25 mg ml
21, respectively.
Steroids. AD, 1,4-androstadiene-3,17-dione (ADD), 19-nor-4-androstene-
3,17-dione (nordion), 3a-hydroxy-5a-pregnane-20-one, 5a-androstan-17b-ol-
3-one (stanolon), 3b-hydroxy-5a-androstane-17-one, and 9a-hydroxy-4-andro-
stene-3,17-dione were obtained from Schering-Plough (Oss, Netherlands).
17b-Hydroxy-4-androstene-3-one (testosterone), 11b-hydrocortisone, 3a-,7a-,
12a-trihydroxy-5b-cholan-24-ioc acid (cholic acid), 4-cholestene-3-one (cho-
lestenone), and 5-cholestene-3b-ol (cholesterol) were obtained from Sigma-
Aldrich, and 4-pregnene-3,20-dione (progesterone) was obtained from ICN
Biomedicals Inc. 1-(5a)-Androstene-3,17-dione, 5a-androstane-3,17-dione, 5b-
androstane-3,17-dione, 5a-androstane-17-one, and 23,24-bis-nor-cholesta-4-ene-
22-oic acid (4-BNC) were obtained from Steraloids. 23,24-bis-nor-cholesta-1,4-
diene-22-oic acid (1,4-BNC) was obtained at near-100% yield using 4-BNC as a
substrate for the KSTD1 enzyme of R. erythropolis SQ1 (13, 30). The steroids
were extracted from the assay mixture with ethyl acetate and dried by evapora-
tion with N2.
Phylogenetic tree construction. MEGA version 4.0.2 was used for the con-
struction of a phylogenetic tree (14). The amino acid sequences used to construct
the phylogenetic tree were obtained from GenBank databases (accession num-
bers are shown in parentheses) as follows: HMPREF0063_12465 (ZP_07718021)
of Aeromicrobium marinum DSM 15272, BamIOP4010DRAFT_2656
(ZP_02890593) of Burkholderia ambifaria IOP40-10, BCAM1620 (YP_002234232)
of Burkholderia cenocepacia J2315, Bcep18194_B1448 (YP_372206) of Burkholderia
sp. 383, Gbro_0919 (YP_003272124) of Gordonia bronchialis DSM 43247,
H16_B0672 (YP_728834) of Ralstonia eutropha H16, MAB_0080c (YP_001700834),
MAB_3627c (YP_001704355), and MAB_4173 (YP_001704900) of Mycobacterium
abscessus ATCC 19977, MAV_0633 (YP_879913) and MAV_3037 (YP_882223) of
Mycobacterium avium 104, Mb3556 (NP_857195) of Mycobacterium bovis AF2122/
97, Mﬂv_1533 (YP_001132803), Mﬂv_1546 (YP_001132816), and Mﬂv_4566
(YP_001135822) of Mycobacterium gilvum PYR-GCK, MintA_010100002014
(ZP_05223666) and MintA_010100021954 (ZP_05227611) of Mycobacterium intra-
cellulare ATCC 13950, Mjls_0287 (YP_001068591) of Mycobacterium sp. JLS,
MkanA1_010100023803 (ZP_04751020) of Mycobacterium kansasii ATCC 12478,
MMAR_5015 (YP_001853274) of Mycobacterium marinum M, Mmcs_0296
(YP_637473) and Mmcs_4640 (YP_641800) of Mycobacterium sp. MCS,
MSMEG_2870 (YP_887190) and MSMEG_5925 (YP_890151) of Mycobacterium
smegmatis strain MC2 155, KshA RV3526 (NP_218043) of Mycobacterium tuberculosis
H37Rv, MUL_4089 (YP_907606) of Mycobacterium ulcerans Agy99, Mvan_2869
(YP_953681), Mvan_5211 (YP_955988), and Mvan_5225 (YP_956002) of Mycobac-
terium vanbaalenii PYR-1, Nfa33560 (YP_119567), Nfa4750 (YP_116681),
Nfa22480 (YP_118459), and Nfa33740 (YP_119585) of Nocardia farcinica IFM
10152, Noca_2518 (YP_923709) of Nocardioides sp. JS614, RALTA_B0514
(YP_001796945) of Cupriavidus taiwanensis, RER_07540 (YP_002764201),
RER_09150 (YP_002764362), RER_13800 (YP_002764827), and RER_51130
(YP_002768560) of Rhodococcus erythropolis PR4, Reut_A1576 (YP_295786) of
Ralstonia eutropha JMP134, REQ_06790 (YP_004005481), REQ_08980
(YP_004005694), REQ_15470 (YP_004006310), REQ_40110 (YP_004008669),
REQ_42740 (YP_004008918), REQ_43730 (YP_004009014), and REQ_45190
(YP_004009156) of R. equi 103S, RHOER0001-0749 (ZP_04388293),
RHOER0001_0834 (ZP_04388135), RHOER0001_2900 (ZP_04382763), and
RHOER0001_4808 (ZP_04386887) of Rhodococcus erythropolis SK121, KshA1
(AAL96829) and KshA2 (ACD11366) of Rhodococcus erythropolis SQ1, KshA
Ro04538 (YP_704482), KshA2 (Ro02490; YP_702453), KshA3 (ro05811;
YP_705746), and KshA4 (ro09003; YP_708205) of Rhodococcus jostii RHA1,
ROP_22170 (YP_002779409), ROP_44530 (YP_002781645), and ROP_58730
(YP_002783065) of Rhodococcus opacus B4, KshA1 (ADY18310), KshA2
(ADY18316), KshA3 (ADY18318), KshA4 (ADY18323), and KshA5 (ADY18328)
of Rhodococcus rhodochrous DSM43269, Sare_2880 (YP_001537697) of Salinis-
pora arenicola CNS-205, SSMG_02043 (ZP_07278003), and SSMG_04623
(ZP_07280583) of Streptomyces sp. AA4, Strop_2672 (YP_001159494) of Salinispora
tropica CNB-440, Tcur_3509 (YP_003301083) of Thermomonospora curvata DSM
43183, and Tpau_3849 (YP_003648763) of Tsukamurella paurometabola DSM
20162.
Electrotransformation of R. rhodochrous strain RG32 with pRRE1-derived
plasmids for functional complementation with kshA genes. Competent cells of
strain RG32 were prepared by growing cell cultures in 250 ml LB broth to an
optical density at 600 nm (OD600) of 0.2 to 1.0. The cultures were incubated on
ice for 1.5 h. All further steps were done at 4°C unless stated otherwise. Cells
were pelleted by centrifugation for 10 min at 5,000 3 g. The cells were washed
twice with MilliQ (125 ml), centrifuged (10 min, 5,000 3 g), washed in 10%
glycerol (25 ml), and centrifuged for 10 min at 2,000 3 g. Cells were resuspended
in 10% glycerol (1 ml) and stored in 100-ml aliquots at 280°C until use. For
electrotransformation, cells were thawed on ice, and 1 ml (0.1 to 0.4 mg) of
plasmid DNA (pA1rho9, pA2rho5, pA3rho5, or pA4rho15 [see Table S1 in the
supplemental material]) was added to 100 ml of competent RG32 cells, mixed,
and incubated for 1 min on ice. The cells were pulsed at 2.5 kV, 25 mF, and 1,000
V (ﬁeld strength, 12.5 kV cm
21). LB broth (1 ml) was added, and the cells were
incubated for 4.5 h at 30°C and 200 rpm prior to plating on selective LB agar
supplemented with apramycin.
Growth on different steroids as a sole carbon and energy source. LB-grown
precultures of R. rhodochrous strains were used to inoculate (1:100) 25 ml of
mineral liquid medium supplemented with representatives of different classes of
steroids, i.e., androstenes, sterols, pregnanes, and bile acids, using 0.5 g liter
21
steroid (AD, cholesterol, progesterone, and cholic acid). Cholesterol was added
as a solid to the medium, autoclaved, and dispersed by sonication. The other
steroids were dissolved in dimethyl sulfoxide as 25-mg ml
21 stock solutions and
then added to the medium. Growth was followed for several days based on
OD600 measurements of cell cultures supplemented with AD or cholic acid. Due
to the low solubilities of progesterone and cholesterol, total protein content was
used to quantify turbidity in cell cultures supplemented with these steroids. Cell
cultures (500 ml) were pelleted by centrifugation and resuspended in 100 ml
bacterial protein extraction reagent (B-PER; Thermo Scientiﬁc). After 5 min,
400 ml MilliQ was added and the mixture was vigorously vortexed and incubated
for 10 min. An aliquot of 160 ml was mixed with 640 ml MilliQ and 200 ml protein
assay reagent (Bio-Rad). Bovine serum albumin (BSA) was used as a standard to
determine the protein content of the sample.
Cholesterol bioconversions. Cultures of R. rhodochrous strains (25 ml) were
grown to an OD600 of approximately 4 in LB broth. Cholesterol (1 g liter
21) was
added, and samples (0.5 ml/culture) were taken at different time points for
analysis of formed products by high-performance liquid chromatography
(HPLC) as described below.
Transcriptomic analysis of R. rhodochrous kshA homologues in steroid-in-
duced cell cultures. Cultures of R. rhodochrous DSM 43269 were grown in
mineral medium (100 ml) supplemented with sodium acetate (2 g liter
21) to an
OD600 of approximately 2. The cultures were then induced with 1 g liter
21
steroid (AD, cholesterol, progesterone, or cholic acid). Noninduced cultures
were used as negative controls. The cultures were induced for 4 h in the cases of
AD, progesterone, and cholic acid and for 24 h in the case of cholesterol. After
centrifugation for 30 min at 10,000 3 g, pelleted cells were frozen in liquid
nitrogen and crushed in an ethanol (70%)-cleaned mortar. Crushed cells were
stored at 280°C. RNA was isolated from the crushed cells using the RNeasy kit
(Qiagen). An on-column DNase treatment was performed by adding DNase
solution to a column that consisted of 40 ml yellow core buffer (Promega), 5 ml
0.09 mM MnCl2, and 5 ml recombinant DNase I (Roche). After incubation at
room temperature for 15 min, 200 ml of stop solution (Promega) was added.
RNA was eluted in 40 ml MilliQ, subsequently treated with Turbo DNase (Am-
bion), and stored at 280°C. PCR was performed on RNA to verify that all DNA
had been removed. If necessary, DNase treatment was repeated until all DNA
was removed from the RNA samples. The PCR mixture (25 ml) consisted of 50
ng RNA, 13 polymerase buffer, 4.0 mM MgCl2, deooxynucleoside triphosphates
(0.2 mM), primers (0.2 mM; Table 1), Taq polymerase (1 U; Roche), and MilliQ
under the following conditions: 5 min at 95°C; 30 cycles of 30 s at 95°C, 30 s at
68°C, and 1 min at 72°C; and 7 min at 72°C. Reverse transcription-PCR (RT-
3932 PETRUSMA ET AL. J. BACTERIOL.
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 PCR) was performed using a SuperScript III Platinum one-step qRT-PCR kit
(Invitrogen). The mixture (25 ml) contained RNA (50 ng), 12.5 ml 23 reaction
buffer, a 0.2 mM concentration of both the forward and the reverse primer (Table
1), MgSO4 to a ﬁnal concentration of 5 mM, 0.5 ml Platinum Taq mix/SuperScript
III and MilliQ. The RNA was incubated at 70°C and kept on ice before being
added to the PCR mixture. The PCR conditions were as described for the DNA
control, preceded by 15 min at 50°C.
Construction of kshA and kshB (co)expression plasmids for E. coli Bl21(DE3)
and E. coli C41(DE3). All kshA and kshB genes were ampliﬁed via PCR using
gene-speciﬁc primers from total DNA isolated from R. rhodochrous DSM43269
(Table 1). Gene cloning in expression vector pET15b and construction of the
kshA-kshB coexpression plasmids pA1rho3 (kshA1), pA2rho2 (kshA2), pA3rho2
(kshA3), and pA5rho2 (kshA5) were performed as described previously (24) (see
Table S1 in the supplemental material). The plasmid used for heterologous
coexpression of kshA4 and kshB has been described elsewhere (24).
Heterologous expression of KSH enzymes in E. coli, protein puriﬁcation, and
KSH enzyme activity assay. Coexpression and copuriﬁcation of KshA and KshB
(together constituting the KSH enzyme), as well as the KSH enzyme activity
assay were essentially performed as described by Petrusma et al. (24). KSH
activity was assayed by measuring the steroid-dependent NADH consumption
over time. The assay mixture (total volume, 500 ml) consisted of 50 mM Tris-HCl
buffer (pH 7.0), 25 to 40 mg of KSH enzyme, NADH (105 mM), and 200 mM
steroid. NADH consumption was recorded with the Soft-max PRO4 (Life Sci-
ence edition) program. KSH enzyme stocks were prepared and stored for a
maximum of 5 days at a concentration of 1 to 2 mg ml
21 in 20% glycerol. The
ratios of coexpressed and copuriﬁed KshADSM43269 homologues and KshB were
determined using Tricine–SDS-PAGE (28) to separate the KshA and KshB
components, followed by densitometry analysis. Uncoupling of the oxygenase
enzyme reaction, which would result in NADH oxidation but not product for-
mation, was checked by HPLC-UV (24) or gas chromatography (GC) analysis to
conﬁrm product formation. The formation of 9OHAD as a product of the
reactions catalyzed by the KshA homologues incubated with AD was analyzed by
electrospray ionization–LC-mass spectrometry (MS). Authentic 9OHAD (Scher-
ing-Plough, Oss, Netherlands) was used as a standard. Conﬁrmation of 9OHAD
formation was also performed using D1-KSTD, leading to the formation of
3-HSA as previously described (24). Authentic 3-HSA (Schering-Plough, Oss,
Netherlands) was used as a standard.
Steroid analysis. Steroids were analyzed by HPLC-UV254 on an Alltima C18
column (250 by 4.6 mm, 5 mm) at 35°C using methanol-water (80:20) with 1%
formic acid as a mobile phase at a ﬂow rate of 1 ml/min. Samples (0.5 ml) were
mixed with 2 ml mobile phase and ﬁltered (0.2 mm) prior to analysis. Samples
(0.5 ml) for GC analysis were mixed with 10% H2SO4 (10 ml) and ethyl acetate
(2 ml), and the upper organic layer was subjected to GC. GC was performed on
a 5% phenyl–5% methoxypoly-siloxane Heliﬂex AT-5 MS column (30 m by 0.25
mm, inner diameter, 0.25 mm; Alltech, Deerﬁeld, IL) with FID-40 detection at
300°C.
RESULTS
Molecular characterization of ﬁve kshA homologues from
Rhodococcus rhodochrous DSM43269. The ﬁve kshA genes, de-
scribed elsewhere for R. rhodochrous DSM43269 (35a), are
similar in length (1,137 to 1,200 nucleotides), share 65 to 70%
identity at the nucleotide level, and encode proteins with 55 to
62% identity at the amino acid level. Bioinformatics analysis of
the KshA homologues showed that all have the typical Rieske
Fe2S2 binding domain (C-X-H-X16,17-C-X2-H) and the non-
heme Fe
21 motif (D-X3-D-X2-H-X4-H) (31). The eight amino
acid residues predicted to be involved in binding of the steroid
substrate in KshA of M. tuberculosis H37Rv, i.e., Val176,
Gln204, Tyr232, Met238, Asn240, Asn257, Phe301, and Trp308
(H37Rv residue numbering per reference 4), were found to be
fully conserved in the KshADSM43269 homologues, with the
exception of Val176, which is an Ile in KshA1, and Asn240,
which is an Asp in all KshADSM43269 homologues except
KshA3.
Analysis of the genetic organization of the kshA homologues
in DSM43269 revealed that kshA1, kshA2, and kshA3 are lo-
cated near genes annotated as steroid catabolic genes (Fig.
1A). The kshA genes of R. rhodochrous DSM43269 and the
proximal genes all have orthologues in R. jostii RHA1 situated
in one of the four previously described steroid catabolic gene
clusters, although their genetic organization varied (Table 2)
(19, 33). Interestingly, a kshB homologue, kshB2, was identi-
ﬁed downstream of kshA1. KshB2 shares 66% amino acid
identity with the KshB described previously (24). Adjacent to
kshA1, kshA3, and kshA4, small putative genes encoding ho-
mologous proteins were found. An alignment of these protein
sequences revealed the presence of four conserved cysteines,
suggesting these genes may encode ferredoxin-type proteins
(Fig. 1B) (18).
Next, phylogenetic analysis was performed on a total of 71
proteins sharing high similarity (.40%) with the KshA homo-
logues of R. rhodochrous DSM43269 (Fig. 2). The phylogenetic
tree showed clustering of these proteins into several groups.
KshA2, KshA4, and KshA5 of strain DSM43269 appeared to
be phylogenetically closely related proteins, belonging to the
same group (Fig. 2). The other two KshADSM43269 homologues
each belong to different groups.
TABLE 1. Primers used in this study
Target Primer name
Product
size
(bp)
Sequence (59–39)
kshA1 KshARho-1 1,191 F, CATATGAGCCTCGGCACTT
CCGAA
R, GCGCTAGCCCGCGGTGGT
GGACT
kshA2 KshaRho-2 1,214 F2, CATATGGCACCGTGGGTT
CCAC
R, GCGTCAGGATCCCGATTC
GGCGG
kshA3 KshaRho-3 1,164 F, GCGCATATGGACATGGCA
CAGATT
R, TCGTCACACCTCCGCTTCC
TGCTT
kshA5 KshaRho-5 1,179 F, CATATGTCCATCGACACCG
CACG
R, GCTCTAGGGGGTCGCGGT
GGAGC
kshA1 KshA1Rho-RT 374 F, AACGGCCGCTGCAAGAA
CATC
R1, TTGACCGTTCGCGTGC
GGAC
kshA2 KshA2Rho-RT 338 F2, CCGTTCCGGAGGTTCC
CACC
R2, TCGGCGTCGACTCGGG
ATCA
kshA3 KshA3Rho-RT 371 F, AACGGCAAGTGCACGGA
CATC
R1, CTGCGTCGCCATGCCC
TTGT
kshA4 KshA4Rho-RT 333 F1, CGAAGCTCGGCCGTAC
CAAG
R1, ATCTGCACACCGGTCT
TGAT
kshA5 KshA5Rho-RT 407 F, GCCTGGACGACCCTCGA
ACGC
R1, GTCTGGCCGTTGGCAT
CGGA
16S
RNA
16SF167Ameth 350 GTGGCCTACCAAGGCGACGA
16SR483Ameth AGACGCGACAAGCCGCCTAC
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 Physiological roles of kshA homologues in catabolism of
different classes of steroids. To gain insight into the possible
physiological roles of each of the KshADSM43269 homologues in
steroid catabolism, growth experiments were performed with
representatives of different classes of steroids, i.e., andro-
stenes, sterols, pregnanes, and bile acids, by using AD, choles-
terol, progesterone, or cholic acid, respectively, as a sole car-
bon and energy source. For this purpose, a 5-fold kshA null
mutant of strain DSM43269, designated R. rhodochrous strain
RG32, was constructed and it lacked kshA1, kshA2, kshA3,
kshA4, and kshA5 (35a). Contrary to wild-type DSM43269, the
kshA null mutant strain RG32 showed no growth on the ste-
roids tested, except for cholesterol (Fig. 3). Growth of strain
RG32 on cholesterol was severely impaired, but not completely
blocked. The slow growth of strain RG32 on cholesterol ap-
peared to be supported by side chain degradation, as evident
from the accumulation of ADD and 1,4-BNC, which is respon-
sible for the release of propionate and acetate, which could be
used as growth substrates (data not shown).
Next, the kshA1, kshA2, kshA3, and kshA4 genes were indi-
vidually reintroduced into strain RG32 under the control of
their native promoter by using plasmid pRRE1 as a shuttle
vector (26) (see Table S1 in the supplemental material). Mu-
tant strain R. rhodochrous RG31, a 4-gene deletion mutant
lacking kshA1 to kshA4, was used to study the physiological
role of kshA5. The growth experiments indicated that kshA2,
kshA3, and kshA5, but not kshA1 and kshA4, were able to
restore the growth of mutant strain RG32 on cholesterol to a
similar level as observed for wild-type strain DSM43269 (Fig.
3). The kshA2 and kshA5 genes also restored the growth of
strain RG32 on both AD and progesterone. Again, kshA1 did
not restore growth of strain RG32 on these substrates, whereas
the kshA3 gene only partially complemented the growth on
AD, progesterone, and cholic acid. Strain RG32 harboring
kshA4 was severely delayed in growth on progesterone,
whereas full complementation was observed on AD. Interest-
ingly, the growth of strain RG32 on cholic acid was restored
only by kshA1 and kshA5, strongly suggesting that kshA1 is
speciﬁcally involved in cholic acid catabolism. Growth on cho-
lic acid was not restored by kshA2, kshA3, or kshA4.
In agreement with our observations in other studies (26,
35a), kshA null mutant strain RG32 was blocked in steroid ring
degradation and accumulated the steroid pathway intermedi-
ates ADD and 1,4-BNC in cholesterol whole-cell bioconver-
sions (Fig. 4). Subsequently, the role of each of the kshA
homologues in cholesterol catabolism was studied in biocon-
version experiments with cholesterol and the RG32 strains
harboring the individual kshA genes (Fig. 4). The results
showed that RG32 cell cultures expressing the kshA2, kshA3,
or kshA5 genes were able to degrade 1,4-BNC and ADD when
FIG. 1. (A) Schematic of the genomic organization of the kshA homologues of R. rhodochrous DSM43269. Annotation of the identiﬁed genes
is provided in Table 2. (B) Alignment of the putative ferredoxin-type proteins (Fd) situated adjacent to kshA1, kshA3, and kshA4. *, conserved
cysteine.
TABLE 2. Comparison of the genetic organization of kshA
homologues of DSM43269 and neighboring genes with
their orthologous genes in R. jostii RHA1
R. rhodochrous
DSM43269
gene
designation
a
R. jostii
RHA1
orthologue
RHA1 steroid
catabolic gene
cluster no.
Annotation in R. jostii
RHA1
Amino
acid
identity
(%)
orf 1* ro05822 3 Acyl-CoA synthetase 54
kshA1 ro05811 3 KshA3 72
Fd1 ro09013 4 Hypothetical protein 30
orf 2 ro05810 3 Dehydrogenase 74
kshB2 ro05833 3 KshB3 74
orf 3 ro09032 4 Short-chain
dehydrogenase
82
orf 4 ro09034 4 IclR family
transcriptional
regulator
66
kshA2 ro09003 4 KshA4 72
hsaA ro09004 4 HsaA4 79
kshA3 ro04538 1 KshA 75
Fd3 ro04537 1 Hypothetical protein 55
kstD ro04532 1 KstD 76
orf 5* ro04742 1 Sensor kinase 61
Fd4 ro02482 2 Hypothetical protein 35
kshA4 ro09003 4 KshA4 57
orf 6 ro02492 2 Cyclohexanone
monooxygenase
64
orf 7 ro04889 Short-chain
dehydrogenase
42
orf 8 ro02480 2 Carveol
dehydrogenase
64
orf 9 ro02481 2 Carveol
dehydrogenase
66
kshA5 ro02490 2 KshA2 72
orf 10* ro02498 2 Aldehyde
dehydrogenase
65
a Four steroid catabolic gene clusters have been identiﬁed in strain RHA1
(indicated by numbers 1 to 4). *, partially known gene sequence.
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 incubated with cholesterol (Fig. 4). This is fully consistent with
the results of the growth experiments using cholesterol as a
substrate (Fig. 3). Strain RG32 harboring kshA4, however, still
accumulated 1,4-BNC, similar to strain RG32 itself, but ADD
wasnotdetected.Theseresultsareinagreementwiththeinability
of kshA4 to complement growth on cholesterol as a sole carbon
and energy source. In contrast, introduction of kshA1 in strain
RG32enabledthepartialdegradationof1,4-BNC,whereasADD
was not converted, consistent with the slowed growth observed on
cholesterol by this recombinant strain.
None of the strain RG32 cell cultures with the various kshA
genes accumulated novel pathway intermediates from choles-
terol, which might have been indicative for a KshA enzyme
with selectivity other than steroid 9a-hydroxylation.
Transcriptional analysis of the kshA homologues. To further
substantiate the involvement of the 5 kshA homologues of
FIG. 2. Phylogenetic tree of bacterial KshADSM43269 enzymes and their orthologues in other actinobacteria and Burkholderia species.
VOL. 193, 2011 KSH ENZYMES OF R. RHODOCHROUS DSM43269 3935
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 DSM43269 in degradation of various classes of steroids, i.e.,
sterols, pregnanes, androstenes, and bile acids, we performed
transcriptional analysis of cell cultures induced with choles-
terol, progesterone, AD, or cholic acid, respectively. Wild-type
R. rhodochrous strain DSM43269 cells were grown on acetate
mineral medium and induced with cholesterol, progesterone,
AD, or cholic acid. RT-PCR performed on isolated RNA from
noninduced cultures showed that none of the kshA homo-
logues was transcribed, indicating that none of the kshA ho-
mologues was constitutively expressed (Fig. 5). The transcrip-
tional proﬁles of induced cells generally conﬁrmed the results
of our growth experiments: expression of kshA1 is induced by
cholic acid, and kshA5 is induced by all steroids tested. Intrigu-
ingly, transcription of kshA2 and kshA4 was induced by cholic
acid in wild-type R. rhodochrous DSM43269, although these
KshA homologues did not appear to support growth on this
bile acid when introduced in strain RG32. Transcriptional
analysis of strain RG32 harboring either kshA2 or kshA4 in-
duced with cholic acid indicated that both enzymes indeed are
expressed in this kshA null mutant strain of R. rhodochrous
DSM43269.
In wild-type R. rhodochrous DSM43269, kshA3 was speciﬁ-
cally induced by AD, whereas only partial complementation of
growth of strain RG32 harboring kshA3 on AD was observed.
FIG. 3. Growth of R. rhodochrous DSM43269 wild-type strain (M), the kshA null mutant strain RG32 (E), recombinant strains RG32
transformed with kshA1 (r), kshA2 (f), kshA3 (Œ), or kshA4 (3), and the kshA1 kshA2 kshA3 kshA4 deletion mutant strain RG31, still harboring
kshA5 (*) on 4-androstene-3,17-dione (A), progesterone (B), cholic acid (C), and cholesterol (D). Growth curves were performed in triplicate. See
Table S2 of the supplemental material for standard errors of the means.
FIG. 4. HPLC elution proﬁles of cholesterol bioconversions by R.
rhodochrous DSM43269 wild type (a), kshA null mutant strain RG32
(b), and recombinant RG32 strains transformed with either kshA1 (c),
kshA2 (d), kshA3 (e), kshA4 (f), or mutant strain RG31 harboring
kshA5 (g).
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 Surprisingly, kshA3 transcripts were not observed when wild-
type DSM43269 cells were induced with cholesterol or proges-
terone, although kshA3 is able to restore growth of strain
RG32 on these steroids.
Heterologous expression and puriﬁcation of KshA homo-
logues of R. rhodochrous DSM43269. Based on the results of
the growth experiments and the transcriptional proﬁling, dif-
ferences in the substrate speciﬁcities of KSH enzymes with any
of these 5 KshA homologues were expected. It also remained
to be conﬁrmed whether all 5 kshA homologues actually en-
code enzymes with 3-ketosteroid 9a-hydroxylase activity or
steroid hydroxylases with a different substrate selectivity, e.g.,
as part of an alternative steroid catabolic pathway. The
KshADSM43269 homologues therefore were individually ex-
pressed in E. coli together with the KshBDSM43269 enzyme to
determine their substrate preference and selectivity.
Cell extracts containing heterologously expressed KshA1,
KshA3, or KshA5 all showed enzyme activities with KshB in a
standard KSH activity assay using AD as steroid substrate.
Consistent with our previous observations, the newly identiﬁed
KshADSM43269 homologues could not be His tag puriﬁed in an
active form (24). Using coexpression of KshA1 or KshA3 with
KshB of strain DSM43269 in E. coli, and subsequent copuri-
ﬁcation, we succeeded in obtaining pure and active KSH en-
zymes. The molar ratios of KshA1:KshB and KshA3:KshB in
the puriﬁed KSH fractions were 1:1 6 0.16 and 1:0.72 6 0.03
(means 6 standard errors of the means), respectively. KshA5
could not be obtained in an active form when we used a single
expression plasmid with both kshA5 and kshB. When express-
ing KshA5 [E. coli BL21(DE3)] and KshB [E. coli C41 (DE3)]
separately, followed by mixing of the two cell extracts, copuri-
ﬁcation resulted in an active KSH protein. The molar ratio of
KshA5:KshB in the puriﬁed KSH fractions was 1:0.59 6 0.04.
Unfortunately, no expression was observed with KshA2 in E.
coli BL21(DE3) or E. coli C41(DE3) despite testing different
expression (induction) times, growth temperatures, and isopro-
pyl-b-D-thiogalactopyranoside concentrations for induction.
Coexpression of KshA2 with KshB in E. coli BL21(DE3) or E.
coli C41(DE3) also did not result in detectable amounts of
KshA2 protein nor KSH activity when we used various steroid
substrates.
Substrate preference and selectivity of KshA enzymes. The
substrate preferences of the KSH enzymes comprised of
KshA1, KshA3, or KshA5 copuriﬁed with KshB were deter-
mined in a KSH enzyme assay based on their initial enzyme
activities on a range of different steroids (Table 3).
All KshADSM43269 homologues were able to use AD and
ADD as substrates. However, substantial differences were ob-
served in their substrate preferences. KshA1 and KshA3
showed higher activity on ADD than on AD, while AD was the
preferred substrate for KshA5. Intriguing was the high prefer-
ence of KshA1 for 4-BNC and 1,4-BNC. On the other hand,
KshA5 had the broadest substrate range, with no apparent
preference for any of the tested substrates, but it is unique in
its ability to convert 5a-androstan-17b-ol-3-one (stanolon) and
11b-hydrocortisone. KSH activity was only observed with 3-ke-
tosteroid substrates and not with 3-hydroxysteroid substrates
(Table 3). The selectivity for C-9 a-hydroxylation of the AD
substrate of all the KshADSM43269 homologues was conﬁrmed
by LC-MS analyses. Extracted steroid products from the reac-
tion mixtures revealed the formation of 9OHAD from AD for
all KSH enzymes. The extracted steroid products from each of
the reaction mixtures were also incubated with puriﬁed KSTD1
enzyme of R. erythropolis SQ1 (13, 30). HPLC with diode array
detection analyses conﬁrmed the disappearance of 9OHAD
and the appearance of 3-HSA (data not shown), the expected
product of 9OHAD D1-dehydrogenation. These experimental
data thus conclusively show that KshA1, KshA3, and KshA5
are 3-ketosteroid 9a-hydroxylase isoenzymes.
DISCUSSION
The well-known catabolic potential of rhodococci is greatly
facilitated by the impressive gene multiplicity (15, 20, 32).
Isoenzymes are involved in degradation pathways of several
aromatic compounds, such as biphenyl, phenylacetate, benzo-
ate, and phthalate in rhodococci (5, 8, 11, 22, 23, 27, 36). This
study reports on multiple kshA genes, encoding the oxygenase
component of KSH, found in R. rhodochrous DSM43269. A
total of ﬁve kshA genes (kshA1 to kshA5) have been identiﬁed
(35a). They were shown to encode homologous KshADSM43269
enzymes with C-9 a-hydroxylation selectivity. Consistently, no
activity was found with any of the KshADSM43269 homologues
on 9OHAD. The latter would have been indicative of a KshA
homologue with enzyme selectivity other than C-9 a-hydroxy-
lation. This is further supported by the ﬁnding that novel hy-
droxylated steroid pathway intermediates from cholesterol
were not detected in any strain of RG32 complemented with a
kshA homologue of DSM43269.
Phylogenetic analysis of the ﬁve KshADSM43269 homologues
revealed that these are distributed across the different phylo-
genetic groups that form the phylogenetic tree, although
KshA2, KshA4, and KshA5 of strain DSM43269 appear to be
phylogenetically closely related proteins (Fig. 2). The kshA
genes of DSM43269 and their neighboring genes all have or-
thologues in R. jostii RHA1, each associated with one of the
FIG. 5. Transcriptional analyses of wild-type R. rhodochrous
DSM43269 cell cultures induced with AD, progesterone, cholic acid,
or cholesterol. RT-PCRs were performed with gene-speciﬁc primers.
16S RNA served as a control.
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 four steroid catabolic gene clusters (Table 2). Accordingly, we
assigned KshA3DSM43269 as a steroid cluster 1 type KshA,
KshA5DSM43269 as a cluster 2 type KshA, KshA1DSM43269 as a
cluster 3 type, and both KshA2DSM43269 and KshA4DSM43269 as
cluster 4 type KshA enzymes. Two groups in the phylogenetic
tree appeared to cluster at the genus level, with one group
representing homologous proteins of Rhodococcus species and
another group representing homologous proteins of Mycobac-
terium species (Fig. 2). Speculatively, these groups may repre-
sent specialized proteins providing catabolic potential to sur-
vive in a speciﬁc environmental niche. The Rhodococcus
cluster, for example, may represent strains capable of growth
on cholic acid, since it includes KshA1DSM43269, a KshA spe-
ciﬁcally linked to cholic acid catabolism. The Mycobacterium
cluster includes Rv3526 of M. tuberculosis H37Rv involved
in cholesterol degradation (10, 33). Interestingly, KshA1
(Ro04538) of RHA1 is the orthologue of Rv3526 (33) but
appears phylogenetically distinct from Rv3526. This may imply
that cholesterol catabolism proceeds differently in Mycobacte-
rium than in Rhodococcus, necessitating distinct KshA en-
zymes.
Bioinformatic analysis of the genetic organization in strain
DSM43269 further revealed the presence of a small open read-
ing frame (ORF), encoding a putative ferredoxin associated
with three out of the ﬁve kshA genes of DSM43269 (Fig. 1B).
Although KSH has been deﬁned as a two-component enzyme
by the classiﬁcation system described by Batie et al. (2), these
small ORFs may encode a third component of KSH. In the
present study KSH activity was obtained when the KshA and
KshB components were jointly expressed in E. coli, in the
absence of these small proteins. However, a ferredoxin com-
ponent could enhance efﬁcient electron transfer between KshA
and KshB. A small putative protein with four conserved cys-
teines is also found in close proximity to kshA (ro04538), kshA2
(ro02490), and kshA4 (ro09003) of R. jostii RHA1: ro04537,
ro02482, and ro09013, respectively. Further studies are needed
to verify a possible role for the putative ferredoxin proteins in
KSH activity.
To provide insight into the functionality of the enzymatic
multiplicity of the oxygenase component of KSH, we tried to
unravel the physiological roles of each of the ﬁve KshA homo-
logues in DSM43269. Enzyme activity assays showed that all
KSH enzymes with KshADSM43269 homologues studied dis-
played KSH activity toward 3-ketosteroids (Table 3). KSH
activity on 3-hydroxysteroid substrates was not observed with
any of the KSH enzymes with KshADSM43269 homologues.
KshA5 appeared the most versatile of the KshADSM43269 ho-
mologues. KshA5 had the broadest substrate range without a
clear substrate preference and was active with D
4, D
1,4, 5a-H,
and 5b-H steroids, as well as with steroids having bulky ali-
phatic side chains. Moreover, expression of kshA5 was induced
by all steroids tested, and the 4-fold kshA mutant, carrying only
kshA5, was capable of growth comparable to wild type on any
of the steroid substrates tested (Fig. 3). KshA5 was also the
sole KshA enzyme of strain DSM43269 capable of using 5a-
androstane-17b-ol-3-one and 11b-hydrocortisone as sub-
strates. Thus, it appears that the other four KshADSM43269
homologues are redundant for growth on steroids. The addi-
tional presence of the other KshA homologues, however, may
aid in the efﬁciency of steroid degradation, allowing the bac-
terium to survive in a competitive environment, like soil. In-
deed, it has been shown that the homologous enzymes of the
TABLE 3. Steroid substrate ranges of four KshA homologues of R. rhodochrous DSM43269
a
Steroid substrate
KshA1 KshA3 KshA4
c KshA5
Enzyme activity
Rel.
activity
(%)
Enzyme activity
Rel.
activity
(%)
Enzyme activity
Rel.
activity
(%)
Enzyme activity
Rel.
activity
(%)
4-Androstene-3,17-dione 2.6 3 10
2 6 10 100 1.7 3 10
2 6 22 100 2.8 3 10
2 6 20 100 1.5 3 10
2 6 30 100
1,4-Androstadiene-3,17-dione 7.5 3 10
2 6 90 288 3.3 3 10
2 6 49 194 2.5 3 10
2 6 20 89 73 6 11 49
4-Androstene-17b-ol-3-one 3.3 3 10
3 6 70 127 1.6 3 10
2 6 40 94 2.8 3 10
2 6 29 101 1.7 3 10
2 6 24 113
4-Pregnene-3,20-dione 1.1 3 10
3 6 94 423 1.9 3 10
2 6 33 112 2.7 3 10
2 6 38 99 1.0 3 10
2 6 12 67
19-Nor-4-androstene-3,17-dione 63 6 7 24 55 6 10 32 2.2 3 10
2 6 25 78 1.6 3 10
2 6 25 107
1-(5a)-Androstene-3,17-dione 59 6 5 23 48 6 5 28 19 3 10
2 6 20 68 14 3 10
2 6 32 93
5a-Androstane-3,17-dione 23 6 13 9 ND ND 1.8 3 10
2 6 19 64 12 3 10
2 6 26 80
5b-Androstane-3,17-dione 50 6 7 19 ND ND 1.6 3 10
2 6 22 58 1.4 3 10
2 6 27 93
5a-Androstane-17b-ol-3-one
(stanolon)
ND ND ND ND ND ND 1.4 3 10
2 6 27 93
11b-Hydrocortisone ND ND ND ND ND ND 1.4 3 10
2 6 29 93
4-Cholestene-3-one
b 34 6 5 13 39 6 5 23 ND ND 39 6 5 26
23,24-Bis-nor cholesta-4-ene-22-oic
acid
1.3 3 10
3 6 1.2 3 10
2 500 2.1 3 10
2 6 33 124 —
d 23 1.2 3 10
2 6 17 80
23,24-Bis-nor-cholesta-1,4-diene-22-
oic acid
1.1 3 10
3 6 1.3 3 10
2 423 3.0 3 10
2 6 44 176 —
d 22 64 6 6 43
a Initial enzyme activities with a 200 mM steroid substrate concentration were calculated in nmol min
21 mg
21 of puriﬁed KSH enzyme. The relative activities are
expressed as percentages compared to activities with 4-androstane-3,17-dione, which was set at 100%. Standard errors of the means (n 5 3) are also reported. ND, no
detectable initial activity. No KSH activity was observed with the following compounds: 5-cholestene-3b-ol (cholesterol), 5a-androstane-17-one, 3a-hydroxy-5a-
pregnane-20-one, 3b-hydroxy-5a-androstane-17-one, 9a-hydroxy-4-androstene-3,17-dione (negative control).
b Due to its limited solubility, this steroid was used at 25 mM. (The lower concentration was also used for 5-cholestene-3b-ol and 3a-hydroxy-5a-pregnane-20-one
@data are not shown#.)
c Data were obtained from reference 24.
d Measurements were performed with enzyme batches with higher activities (initial activity on 4-androstane-3,17-dione of 512 6 62 nmol min
21 mg
21 of puriﬁed KSH
enzyme) than those described in reference 24 due to the slightly optimized expression and puriﬁcation methods used in our study. However, the relative activities
remained constant. For chemical structures of the tested steroids, see Fig. S1 in the supplemental material.
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 class IIA Rieske oxygenase carbazole 1,9a-dioxygenase of Sph-
ingomonas sp. strain KA1 do not broaden the substrate range,
but rather facilitate more efﬁcient growth (29). It has also been
suggested that the extensive gene redundancy in rhodococci
makes the bacteria better equipped to adapt to new carbon
sources (23).
The versatility of KshA5 is in strong contrast with KshA1,
which appears to be dedicated to cholic acid degradation. The
kshA1 gene, but not kshA2, kshA3, or kshA4, complemented
the growth of RG32 on cholic acid to the wild-type level (Fig.
3). In addition, kshA1 was induced only during growth on
cholic acid in DSM43269 (Fig. 5). KshA1 is a steroid cluster 3
type KshA, and we thus hypothesize that steroid cluster 3 in R.
jostii RHA1 is involved in cholic acid. KshA1 is highly active on
4-BNC and 1,4-BNC compared to the other KshADSM43269
homologues (Table 3). Indeed, compounds such as 7a,12a-
dihydroxy-23,24-bis-nor-cholesta-4-ene-22-oic acid and 23,24-
bisnorcholesta-1,4-diene-22-oic acid have been found as inter-
mediates in cholic acid degradation (3, 16). Expression of
kshA2 and kshA4, both encoding steroid cluster 4 type KshAs,
was also induced by cholic acid in wild-type strain DSM43269
(Fig. 5). These genes, however, do not complement the RG32
phenotype in growth on this steroid (Fig. 3). Since the enzymes
were expressed in the R. rhodochrous mutant strain RG32
background, it seems that the cholic acid catabolic pathway
intermediates are not substrates for the KshA2 and KshA4
isoenzymes.
Gene expression of kshA1 was also induced by cholesterol,
albeit at a very low level. The kshA1 gene appeared of no
physiological relevance for growth on cholesterol: kshA1 was
unable to restore growth of strain RG32 on cholesterol, and
accumulation of ADD and 1,4-BNC from cholesterol by a
kshA1-complemented RG32 strain was still observed (Fig. 3),
while both ADD and 1,4-BNC were preferred substrates of
KshA1 (Table 3).
KshA3 is a steroid cluster 1 type kshA (Fig. 2). Steroid
cluster 1 is named after the cholesterol catabolic gene cluster
found in R. jostii RHA1 (33), thus suggesting that KshA3 is
involved in cholesterol degradation. Indeed, kshA3 restores
growth of strain RG32 on cholesterol to the wild-type level,
conﬁrming a role for kshA3 in cholesterol catabolism (Fig. 3).
However, transcriptional analysis with the wild-type strain
DSM43269 showed that kshA3 is induced in the presence of
AD, but not with cholesterol or any of the other steroids
tested. We hypothesize that the formation of AD(D) in strain
RG32 carrying kshA3 induces kshA3 expression, after which
the substrate range of KshA3 allows full complementation of
cholesterol degradation in strain RG32. This strongly implies
that cholesterol degradation by wild-type DSM43269 is not
accompanied by the formation of AD(D) able to induce kshA3
expression. Several kshA homologues are induced by choles-
terol in strain DSM43269 (Fig. 5), likely preventing the accu-
mulation of AD(D) by premature ring opening and thereby
kshA3 expression during cholesterol catabolism. Intriguingly,
kshA4 is strongly induced by cholesterol but unable to restore
growth on cholesterol (Fig. 5). The substrate proﬁle for KshA4
indicated that this homologue has a subtle substrate range (24)
(Table 3). Indeed, KshA4 is the only KshA with no detectable
activity on cholestenone. In addition, both 4-BNC and 1,4-
BNC are poor substrates (Table 3). Consistent with those ﬁnd-
ings, cholesterol bioconversions with a kshA4-complemented
RG32 recombinant strain showed complementation in ADD
degradation, but 1,4-BNC still accumulated (Fig. 4). The re-
sults taken together suggest that kshA4 is induced by choles-
terol but only acts in the degradation pathway after the side
chain has been cleaved.
In conclusion, this study provides insight into the KshA
multiplicity found in many Rhodococcus species. The KshA
homologues of R. rhodochrous DSM43269 show high sequence
similarity. They have the same enzymatic selectivity (C-9 a-hy-
droxylation) and also show overlap in their substrate range.
However, the isoenzymes also show interesting differences,
each displaying a unique induction pattern and substrate
range. Furthermore, both the in vitro and in vivo studies indi-
cated that the KshA homologues are involved in the degrada-
tion of speciﬁc steroids, acting at different levels in the steroid
degradation pathway. The data suggest that the presence of
multiple kshA genes in the R. rhodochrous DSM43269 genome
facilitates a dynamic and ﬁne-tuned response to the environ-
mental changes encountered by the bacterium.
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